Research programme: antibiotic-resistant infection therapeutics - Agile SciencesAlternative Names: 2-AI compounds; Agilyte; AGL-110; AGL-503
Latest Information Update: 10 Jun 2016
At a glance
- Originator North Carolina State University
- Developer Agile Sciences
- Class Imidazoles; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bacterial infections; Pseudomonal infections; Wound infections